Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Age and sex differences in burnout, career satisfaction, and well-being in US neurologists.

LaFaver K, Miyasaki JM, Keran CM, Rheaume C, Gulya L, Levin KH, Jones EC, Schwarz HB, Molano JR, Hessler A, Singhal D, Shanafelt TD, Sloan JA, Novotny PJ, Cascino TL, Busis NA.

Neurology. 2018 Nov 13;91(20):e1928-e1941. doi: 10.1212/WNL.0000000000006497. Epub 2018 Oct 10.

PMID:
30305448
2.

Burnout, wellness, and the future of our profession.

Cascino TL.

Neurology. 2018 Feb 6;90(6):275-277. doi: 10.1212/WNL.0000000000004929. No abstract available.

PMID:
29438021
3.

Author response: Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016.

Levin KH, Shanafelt TD, Keran CM, Busis NA, Foster LA, Molano JRV, O'Donovan CA, Ratliff JB, Schwarz HB, Sloan JA, Cascino TL.

Neurology. 2018 Jan 30;90(5):248. doi: 10.1212/WNL.0000000000004882. No abstract available.

PMID:
29378925
4.

Author response: Burnout, career satisfaction, and well-being among US neurologists in 2016.

Busis NA, Shanafelt TD, Keran CM, Levin KH, Schwarz HB, Molano JR, Vidic TR, Kass JS, Miyasaki JM, Sloan JA, Cascino TL.

Neurology. 2017 Oct 10;89(15):1650-1651. doi: 10.1212/WNL.0000000000004484. Epub 2017 Oct 9. No abstract available.

PMID:
28993531
5.

Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016.

Miyasaki JM, Rheaume C, Gulya L, Ellenstein A, Schwarz HB, Vidic TR, Shanafelt TD, Cascino TL, Keran CM, Busis NA.

Neurology. 2017 Oct 17;89(16):1730-1738. doi: 10.1212/WNL.0000000000004526. Epub 2017 Sep 20.

PMID:
28931640
6.

Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016.

Levin KH, Shanafelt TD, Keran CM, Busis NA, Foster LA, Molano JRV, O'Donovan CA, Ratliff JB, Schwarz HB, Sloan JA, Cascino TL.

Neurology. 2017 Aug 1;89(5):492-501. doi: 10.1212/WNL.0000000000004135. Epub 2017 Jun 30.

PMID:
28667180
7.

Burnout, career satisfaction, and well-being among US neurologists in 2016.

Busis NA, Shanafelt TD, Keran CM, Levin KH, Schwarz HB, Molano JR, Vidic TR, Kass JS, Miyasaki JM, Sloan JA, Cascino TL.

Neurology. 2017 Feb 21;88(8):797-808. doi: 10.1212/WNL.0000000000003640. Epub 2017 Jan 25.

8.

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.

Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W, Buckner JC.

Neuro Oncol. 2011 May;13(5):530-5. doi: 10.1093/neuonc/nor044.

9.

Preparing professionals to serve in a reformed health care system.

Cascino TL, Cortese DA.

Mayo Clin Proc. 2009 Oct;84(10):862-3. doi: 10.1016/S0025-6196(11)60502-8. No abstract available.

10.

Education scholarship.

Habermann TM, Cascino TL.

Mayo Clin Proc. 2006 Nov;81(11):1423-4. No abstract available.

PMID:
17120395
11.

Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.

Buckner JC, Ballman KV, Michalak JC, Burton GV, Cascino TL, Schomberg PJ, Hawkins RB, Scheithauer BW, Sandler HM, Marks RS, O'Fallon JR; North Central Cancer Treatment Group 93-72-52; Southwest Oncology Group 9503 Trials.

J Clin Oncol. 2006 Aug 20;24(24):3871-9.

PMID:
16921039
12.

Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.

Marshall NE, Ballman KV, Michalak JC, Schomberg PJ, Burton GV, Sandler HM, Cascino TL, Jaeckle KA, Buckner JC.

J Neurooncol. 2006 May;77(3):315-20.

PMID:
16273313
13.

Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1147-52.

PMID:
15001257
14.

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.

Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM.

Cancer. 2001 Jul 15;92(2):420-33.

PMID:
11466698
15.

A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.

Burch PA, Bernath AM, Cascino TL, Scheithauer BW, Novotny P, Nair S, Buckner JC, Pfeifle DM, Kugler JW, Tschetter LK.

Invest New Drugs. 2000 Aug;18(3):275-80.

PMID:
10958598
16.

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.

Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15.

PMID:
10613302
17.

Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.

Buckner JC, Malkin MG, Reed E, Cascino TL, Reid JM, Ames MM, Tong WP, Lim S, Figg WD.

Mayo Clin Proc. 1999 Feb;74(2):137-45.

PMID:
10069350
18.

Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.

Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC 4th, Ingle JN, Cascino TL.

Neurosurgery. 1999 Jan;44(1):67-73.

PMID:
9894965
19.

Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.

Rajkumar SV, Buckner JC, Schomberg PJ, Reid JM, Bagniewski PJ, Ames MM, Cascino TL, Marks RS.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):969-75.

PMID:
9869217
20.

Outcome of peroneal neuropathies in patients with systemic malignant disease.

Rubin DI, Kimmel DW, Cascino TL.

Cancer. 1998 Oct 15;83(8):1602-6.

PMID:
9781954

Supplemental Content

Loading ...
Support Center